(Q31110945)

28 June 2017

1 reference

title

Imaging biomarkers and their role in dementia clinical trials (English)

1 reference

28 June 2017

0 references

1 reference

1

Howard Chertkow

0 references

Sandra Black

series ordinal

2

object named as

Sandra Black

1 reference

28 June 2017

language of work or name

1 reference

1 March 2007

1 reference

Canadian Journal of Neurological Sciences

28 June 2017

published in

1 reference

28 June 2017

volume

34 Suppl 1

1 reference

28 June 2017

page(s)

S77-83

1 reference

Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Positron emission tomographic (PET) studies in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Heterogeneity in Alzheimer's disease: progression rate segregated by distinct neuropsychological and cerebral metabolic profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Abnormalities of Energy Metabolism in Alzheimer's Disease Studied with PETa

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Alzheimer's disease: focal cortical changes shown by positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Clinical history, brain metabolism, and neuropsychological function in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Specificity of brain activation patterns in people at genetic risk for Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Magnetic resonance spectroscopy in AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

A 1H MRS study of probable Alzheimer's disease and normal aging: implications for longitudinal monitoring of dementia progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Mild cognitive impairment and Alzheimer disease: regional diffusivity of water

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

(1)H-MR spectroscopy differentiates mild cognitive impairment from normal brain aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Randomized, Placebo-Controlled Trial of the Effects of Donepezil on Neuronal Markers and Hippocampal Volumes in Alzheimer’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Vitamin E and donepezil for the treatment of mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Hippocampal formation glucose metabolism and volume losses in MCI and AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Effects of long-term Donepezil therapy on rCBF of Alzheimer's patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

The effect of cholinesterase inhibitors on the regional blood flow in patients with Alzheimer's disease and vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Magnetization transfer ratio in mild cognitive impairment and dementia of Alzheimer's type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Characterization of white matter damage in ischemic leukoaraiosis with diffusion tensor MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Cerebral blood flow and cognitive responses to rivastigmine treatment in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Utility of simultaneous brain, CSF and hyperintensity quantification in dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Single photon emission tomography using 99mTc-HM-PAO in the investigation of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Retrosplenial cortex (BA 29/30) hypometabolism in mild cognitive impairment (prodromal Alzheimer's disease)

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Preclinical prediction of Alzheimer's disease using SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Longitudinal changes in lateral ventricular volume in patients with dementia of the Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Temporal lobe atrophy on magnetic resonance imaging in the diagnosis of early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

The diagnosis of dementia with single photon emission computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Rates of hippocampal atrophy correlate with change in clinical status in aging and AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E epsilon4 allele.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Subjective memory complaints: objective neural markers in patients with Alzheimer's disease and major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Activation of cerebral blood flow during a visuoperceptual task in patients with Alzheimer-type dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

The role of biomarkers in clinical trials for Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Fully automatic diagnostic system for early- and late-onset mild Alzheimer's disease using FDG PET and 3D-SSP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

The cortical topography of temporal lobe hypometabolism in early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Is there a typical pattern of brain SPECT imaging in Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

Measuring the neuromodulatory effects of drugs in man with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

7 January 2021

Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological grading

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

7 January 2021

Reliability of brain volumes from multicenter MRI acquisition: a calibration study.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

7 January 2021

Volumes of the entorhinal and perirhinal cortices in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

7 January 2021

Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

7 January 2021

Application of PET in dementia disorders.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

7 January 2021

Positron emission tomography with (18F)methylspiperone demonstrates D2 dopamine receptor binding differences of clozapine and haloperidol

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

7 January 2021

Pathological and positron emission tomographic correlations in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

7 January 2021

MRI of entorhinal cortex in mild Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

7 January 2021

The binding of 2-(4'-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

7 January 2021

Activation PET as an instrument to determine therapeutic efficacy in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

7 January 2021

A new rating scale for age-related white matter changes applicable to MRI and CT.

1 reference

https://api.crossref.org/works/10.1017%2FS031716710000562X

7 January 2021

10.1017/S031716710000562X

Identifiers

DOI

1 reference

28 June 2017

1 reference